Quantcast

AANMA Announces Launch of Free Web-Based Education Program for Patients Transitioning From CFC to HFA Inhalers

December 3, 2008

FAIRFAX, Va., Dec. 3 /PRNewswire-USNewswire/ — Allergy & Asthma Network
Mothers of Asthmatics (AANMA) announced today that a new Web-based video
geared to help people successfully manage the transition from CFC albuterol
inhalers to HFA inhalers is now available at its Web site,
www.breatherville.org. Smart Moves to an HFA Inhaler uses technology that
allows viewers to ask questions in everyday language and immediately receive a
response with relevant, highly focused answers. Users can obtain valuable
information about why inhalers are changing, the differences between newer and
older inhalers, cost concerns and how to use new HFA inhalers.

“We created this video to help patients and their families learn more
about this federal mandate, as a significant number of patients are still not
aware of how to safely go about making this change,” said Nancy Sander,
president and founder of AANMA. “At the end of the year, inhalers are
changing. These changes are mandatory, and there are important decisions to
make about treatment options that require thoughtful consideration of the
patient’s medical history and current respiratory health status.”

In less than 30 days, life-saving albuterol inhalers used by nearly 40
million patients with respiratory disorders will no longer be sold. After
December 31, 2008, it will no longer be permissible to manufacture or sell
albuterol inhalers in the United States that contain chlorofluorocarbon (CFC)
propellants, because they destroy the Earth’s ozone layer. These inhalers have
been replaced with four distinct non-CFC propelled alternatives, which contain
hydrofluoroalkane (HFA) propellant.

While the transition has been forthcoming for some time, data from IMS
Health show that an estimated 14 million CFC prescriptions have yet to be
transitioned to HFA MDIs.(1) The absence of a medically responsible transition
protocol leaves patients unknowingly exposed to health risks beyond their
control.

Patients with asthma, COPD and other respiratory conditions use albuterol
at the first sign of symptoms, before exercise and when experiencing breathing
exacerbations. Because there are significant differences between CFC and HFA
inhalers, patients and medical professionals need to have the opportunity to
make the switch in a medically responsible way.

The Web module is hosted by former CNN Medical correspondent Rea Blakey,
and supported by an educational grant from Sepracor.

For more information about the MDI transition, please visit AANMA’s MDI
Transition Web page at www.mditransition.org. Patients seeking information
can also call AANMA’s Patient Support Center at 800-315-8056.

About AANMA

Founded in 1985, Allergy & Asthma Network Mothers of Asthmatics is the
leading national nonprofit family organization dedicated to eliminating
suffering and death due to asthma, allergies and related conditions. AANMA’s
core areas of expertise are education, advocacy and outreach. Call
800.878.4403 or visit www.breatherville.org.

(1) IMS NPA, August 22, 2008

SOURCE Allergy & Asthma Network Mothers of Asthmatics


Source: newswire



comments powered by Disqus